Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL106153

CCCC[N+](CCCC)(CCCC)CCCC.CCCC[N+](CCCC)(CCCC)CCCC.O=C([O-])C(=O)[O-]

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.63
SLC22A2 O15244 1/20 0.55
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
ALOX12 P18054 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
CES2 O00748 4/20 0.48
CES1 P23141 4/20 0.48
DNM1 Q05193 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL9505237 0.97 SLC22A1 (0.60) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL27860993 0.97 SLC22A1 (0.60) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL9505231 0.95 SLC22A1 (0.57) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL16343940 0.95 SLC22A1 (0.63) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL17768456 0.93 SLC22A1 (0.55) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Oxalic Acid SCHEMBL1052717 0.92 SLC22A1 (0.65) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL18109154 0.92 SLC22A1 (0.60) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL16093909 0.92 SLC22A1 (0.60) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL3488443 0.92 SLC22A1 (0.60) SLC22A1SLC22A2ALDH1A1TP53CYP3A4
Tetrabuthylammonium SCHEMBL3488441 0.92 SLC22A1 (0.60) SLC22A1SLC22A2ALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115785425-A Carbon dioxide-based polycarbonate-polyether block polyol and preparation method thereof 佛山市中天融新材料科技有限公司 2023-03-14 CN claimed
CN-115073458-A Preparation method of avibactam sodium 山东致泰医药技术有限公司 2022-09-20 CN claimed
US-8389178-B2 Electrochemical energy storage device based on carbon dioxide as electroactive species U.S. DEPARTMENT OF ENERGY (US) 2013-03-05 US claimed
EP-2011798-B1 Preparation of platinum (II) complexes PLATCO TECHNOLOGIES PROPRIETARY LTD (ZA) 2011-06-29 EP claimed
US-7956208-B2 Preparation of platinum (II) complexes PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2011-06-07 US claimed
US-7888523-B2 Preparation of platinum(II) complexes PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2011-02-15 US claimed
US-20100330435-A1 ELECTROCHEMICAL ENERGY STORAGE DEVICE BASED ON CARBON DIOXIDE AS ELECTROACTIVE SPECIES U.S. DEPT. OF ENERGY (US) 2010-12-30 US claimed
US-20090299085-A1 PREPARATION OF PLATINUM(II) COMPLEXES PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2009-12-03 US claimed
US-20090281319-A1 PREPARATION OF PLATINUM (II) COMPLEXES PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2009-11-12 US claimed
US-7589225-B2 Preparation of platinum(II) complexes PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2009-09-15 US claimed
EP-1979369-A1 PREPARATION OF PLATINUM (LL) COMPLEXES Platco Technologies (Proprietary) Limited (ZA) 2008-10-15 EP claimed
US-20080064895-A1 Preparation of Platinum(II) Complexes PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2008-03-13 US claimed
WO-2007085957-A1 PREPARATION OF PLATINUM (LL) COMPLEXES PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2007-08-02 WO claimed
EP-1789427-A1 PREPARATION OF PLATINUM(II) COMPLEXES Platco Technologies (Proprietary) Limited (ZA) 2007-05-30 EP claimed
WO-2006024897-A1 PREPARATION OF PLATINUM(II) COMPLEXES PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) 2006-03-09 WO claimed
EP-1142049-B1 HYDROFLUORIC ACID SCAVENGER DANIONICS AS (DK) 2002-09-18 EP claimed
WO-2000042672-A9 HYDROFLUORIC ACID SCAVENGER DANIONICS AS (DK) 2001-11-15 WO claimed
EP-1142049-A2 HYDROFLUORIC ACID SCAVENGER DANIONICS A/S (DK) 2001-10-10 EP claimed
WO-2000042672-A2 HYDROFLUORIC ACID SCAVENGER DANIONICS A/S (DK) 2000-07-20 WO claimed
EP-0398615-B1 PROCESS FOR SOLUBILIZING POLYANIONIC BACTERIAL POLYSACCHARIDES IN APROTIC SOLVENTS MERCK & CO. INC. (US) 1993-07-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090299085-A1 PREPARATION OF PLATINUM(II) COMPLEXES SLCO4C1, OTC, SLC10A6 SLC22A1 283/4885SLC22A2 261/4885ALDH1A1 3900/4885
US-20080064895-A1 Preparation of Platinum(II) Complexes SLCO4C1, SLC10A6, OTC SLC22A1 272/4885SLC22A2 254/4885ALDH1A1 3885/4885
US-20090281319-A1 PREPARATION OF PLATINUM (II) COMPLEXES OAT, OTC, POLR2E SLC22A1 857/4885SLC22A2 702/4885ALDH1A1 1641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.